John F. DiPersio, MD, PhD¹, Guenther Koehne, MD, PhD², Nirali N. Shah, MD³, Lea Bernard, MD⁴, Hyung C Suh, MD, PhD⁵, Divya Koura, MD⁶, Miguel Angel Perales, MD⁷, Roni Tamari, MD⁸, Muhammad Umair Mushtaq⁹, Joseph E. Maakaron, MD¹⁰, Michael R. Loken, PhD^11*, Darren A Stanizzi^12*, Melissa M. Lee-Sundlov, Ph.D.^12*, Sanjana Thosar^12*, Sharon L Hyzy^12*, Glen D Raffel, MD, PhD¹² and Brenda W Cooper, MD¹³

¹Division of Oncology, Washington University School of Medicine, Saint Louis, MO
²Baptist Health South Florida, Miami Cancer Institute, Miami, FL
³Pediatric Oncology Branch, NIH, Bethesda, MD
⁴Hematology-Oncology and Cell Therapy University Institute, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, QC, Canada
⁵Stem Cell Transplantation and Cellular Therapy Program, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
⁶UCSD Moores Cancer Center, San Diego, CA
⁷Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Department of Medicine, Weill Cornell Medicine, New York, NY
⁹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
¹⁰Division of Hematology, Oncology, and Transplantation, University of Minnesota Medical Center, Minneapolis, MN
¹¹Hematologics, Inc., Seattle, WA
¹²Vor Bio, Cambridge, MA
¹³Department of Hematology and Stem Cell Transplant, University Hospitals Seidman Cancer Center, Cleveland, OH

Javier Zambrano Marquez, MD^1*, Teresa Bernal, MD, PHD^2,3,4,5*, Rebeca Rodriguez-Veiga, MD, PhD^6*, Jose Antonio Perez Simon^7*, Montserrat Arnan, MD, PhD^8*, Susana Vives, MD^9,10*, Juan Miguel Bergüa Burgues^11*, Joaquin Martinez Lopez, PhD, MD^12*, Vicente Rubio^13*, Joaquin Sanchez-Garcia, MD, PhD^14*, Josefina Serrano, MD^15*, Ainhoa Fernandez Moreno^16,17,18*, Andres Novo Garcia, PhD^19*, Inmaculada Marchante Cepillo^20*, Pilar Herrera Puente^21*, Carlos Rodriguez Medina, MD^22*, Laura Torres Miñana^23*, Victor Noriega Concepcion, MD, PhD^24*, Marta Cervera Calvo, PhD^25*, Ana Alfonso Pierola, MD, PhD^26*, Evelyn Acuña-Cruz, MD^27*, Isabel Cano-Ferri, MD^27*, Maria Teresa Gómez Casares^28*, David Martinez-Cuadron, PhD²⁷ and Pau Montesinos, PhD, MD^29,30,31*

¹Instituto de Investigación Sanitaria del Principado de Asturias, Avilés, Spain
²Instituto Universitario de Oncología del Principado de Asturias, Oviedo, Spain
³Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain
⁴Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain
⁵Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Asturias, Spain
⁶Department of Hematology, Hospital Universitari i Politècnic La Fe, Valencia, Spain
⁷University Hospital Virgen del Rocío, Sevilla, Spain
⁸Institut Català d’Oncologia - Hospital Duran i Reynals, Barcelona, Spain
⁹Hematology Department, Institut Catala d'Oncologia - Hospital Germans Trias i Pujol, Badalona, Spain
¹⁰Hospital Germans Trias i Pujol, Badalona, ESP
¹¹Hematology, Hospital San Pedro Alcántara, Caceres, Spain
¹²Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
¹³Hospital Jerez de la Fontera, Jerez De La Frontera, ESP
¹⁴Hospital Universitario Reina Sofía, Córdoba, Spain
¹⁵Department of Hematology, Hospital Universitario Reina Sofía, IMIBIC.UCO, Cordoba, ESP
¹⁶Hospital Universitario Central de Asturias, Oviedo, Spain
¹⁷Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain
¹⁸Instituo Universitario de Oncología del Principado de Asturias, Oviedo, Spain
¹⁹Hospital Universitario Son Espases, Palma de Mallorca, Spain
²⁰Hospital Universitario Puerta del Mar, Cádiz, Spain
²¹Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain
²²Hospital UNiversitario de Gran Canaria Dr. Negrín, Gran Canaria, Spain
²³Complejo Hospitalario Universitario Insular materno Infantil, Gran Canaria, Spain
²⁴Complejo Hospitalario Universitario ACoruña, A Coruña, ESP
²⁵HOSPITAL JOAN XXIII, MADRID, MADRID, ESP
²⁶Clínica Universitaria de Navarra, Pamplona, Spain
²⁷Hospital Universitario LaFe, Valencia, Spain
²⁸Hospital Universitario Doctor Negrín, Las Palmas, Spain
²⁹Programa Español de Tratamientos en Hematologia, PETHEMA, Valencia, Spain
³⁰Instituto de Investigación Sanitaria La Fe (IISLAFE), Hospital Universitari i Politècnic La Fe, Valencia, Spain
³¹Hospital Universitari i Politecnic la Fe, Valencia, and CIBERONC Instituto de Salud Carlos III, Valencia, Spain

Arjan A. van de Loosdrecht, MD, PhD¹, Eva-Maria Wagner Drouet^2*, Uwe Platzbecker, MD³, Tobias A.W. Holderried, MD^4*, Catharina Van Elssen, MD, PhD^5*, Aristoteles Giagounidis, MD⁶, Soren Lehmann, MD, PhD^7*, Jacqueline Cloos, PhD^8*, Hester Van Zeeburg^9*, Jeroen Rovers, MD, PhD^10* and Bjorn T. Gjertsen, MD, PhD¹¹

¹Department of Hematology, Amsterdam UMC, location VUmc, CCA, Amsterdam, Netherlands
²University medical center Mainz, Dept of Hematology and Oncology, Mainz, Germany
³University Hospital Leipzig, Leipzig, Germany
⁴Universitaetsklinikum Bonn (UKB), Bonn, Germany
⁵Maastricht University Medical Centre, Maastricht, Netherlands
⁶Dept. for Oncology, Hematology and Palliative Care, Marienhospital Düsseldorf, Düsseldorf, Germany
⁷Department of Medical Sciences, Hematology, Uppsala University, University Hospital Uppsala, Uppsala, Sweden
⁸Cancer Center Amsterdam, Department of Hematology, Amsterdam UMC, Location VUMC, Amsterdam, Netherlands
⁹Mendus AB, Leiden, Netherlands
¹⁰Mendus AB, Stockholm, Sweden
¹¹Department of Medicine, Haematology section, Haukeland Universitetssjukehus, Bergen, Norway

Abhishek Maiti, MBBS¹, Pierre Yves Dumas, MD, PhD^2*, Pierre Peterlin^3*, Daniel Morillo, MD^4*, Jose Torregrosa^5*, Paul B. Koller, MD⁶, Maelle Mairesse^7*, Patrick Brune^8*, Emmanuel Valenitn^7*, Aude De Gassart, PhD^8*, Katrien Lemmens^9*, Daniel Olive, MD, PhD^10*, Naval Daver, MD¹¹, Stephan Braun, MD, PhD⁸ and Sylvain Garciaz, MD^12*

¹Department of Leukemia, The University of Texas Health Science Center At Houston, Houston, TX
²Department of Clinical Hematology, Bordeaux University Hospital, PESSAC, France
³Hematology Department, Hôtel-Dieu University Hospital, NANTES CEDEX 1, France
⁴START Madrid - Fundación Jiménez Díaz, Madrid, Spain
⁵Poitiers University Hospital, Poitiers, FRA
⁶Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
⁷Imcheck Therapeutics SAS, Marseille, France
⁸ImCheck Therapeutics, Marseille, France
⁹ImCheck Therapeutics, Marseille, AL, France
¹⁰Institut Paoli Calmettes, Centre de Recherche en Cancérologie de Marseille (CRCM), Marseille, France
¹¹MD Anderson Cancer Center, Houston, TX
¹²Institut Paoli-Calmettes, MARSEILLE, France

Joshua F. Zeidner, MD¹, Omer Jamy, MD^2,3, Bradley Christensen, MD^4*, Sharif S. Khan, MD⁵, Dragan Cicic, MD^6,7 and Tapan M. Kadia, MD^8,9,10

¹Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
²O'Neal Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, AL
³University of Alabama Medical Center, Birmingham, AL
⁴Baylor Scott & White Research Institute, Dallas, TX
⁵Bon Secours Hematology and Oncology - St. Francis Cancer Center, Greenville, SC
⁶SELLAS Life Sciences Group, Inc., Brooklyn, NY
⁷SELLAS Life Sciences Group, Inc., New York, NY
⁸MD Anderson, Houston, TX
⁹MD Anderson Cancer Center, Houston, TX
¹⁰Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Yesid Alvarado Valero, MD¹, Rachel J. Cook, MD, MS², Shira N. Dinner, MD³, Michael Keng, MD⁴, Kebede Begna, MD⁵, Sameem Abedin, MD⁶, MHD Monzr M. Al Malki, MD⁷, Vijaya Raj Bhatt, MD⁸, Nathalie Javidi-Sharifi, MD, PhD⁹, Prabhu Rajagopolan, PhD^10*, Sandra Wiley, PhD, MSc¹¹, Richard G Ghalie, MD, MBA¹¹ and Matthew S. Davids, MD, MMSc¹²

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Oregon Health & Science University, Portland, OR
³Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
⁴Department of Medicine, Division of Hematology and Oncology, University of Virginia Medical Center Comprehensive Cancer Center, Charlottesville, VA
⁵Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
⁶Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
⁷Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
⁸The Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE
⁹Dana-Farber Cancer Institute, Boston
¹⁰PR Consulting, Mountain Lakes
¹¹MEI Pharma, San Diego, CA
¹²Department of Medical Oncology, Dana-Farber Cancer Institute, Inc., Boston, MA

Depei Wu, MD, PhD¹, Ying Wang^1*, Suning Chen, MD, PhD^2*, Yuhua Li^3*, Rui Huang, MD^4*, Jinhai Ren, MD^5*, Xiaoling Guo, MD^5*, Yan Li, MD^6*, Mingyuan Sun, MD^6*, Xudong Wei, MD, PhD^7*, Ruihua Mi, MD^8*, Xiaoyu Zhu⁹, Anyou Wang, MD^9*, He Huang^10*, Yi Luo¹¹, Dengju Li, PhD¹², Jin Yin, MD^13*, Xiaojing Yan¹⁴, Ran Gao, MD^14*, Fei Li¹⁵, Yu Wang^16*, Bryan Huang^16* and Ye Hua, MD¹⁶

¹The First Affiliated Hospital of Soochow University, Suzhou, China
²Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China
³Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, China
⁴Zhujiang Hospital, Southern Medical University, Guangzhou, China
⁵The Second Hospital of Hebei Medical University, Shijiazhuang, China
⁶Institute of Hematology and Blood Diseases Hospital, Tianjin, China
⁷Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
⁸Henan Cancer Hospital, Zhengzhou, China
⁹Anhui Provincial Hospital, Hefei, China
¹⁰The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
¹¹Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
¹²Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
¹³Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
¹⁴The First Hospital of China Medical University, Shenyang, China
¹⁵Department of Hematology, Jiangxi Clinical Research Center for Hematologic Disease, Jiangxi Provincial Key Laboratory of Hematological Diseases, The First Affiliated Hospital, Jiangxi Medical College, Nanchang, China;, Nanchang, China
¹⁶BioNova Pharmaceuticals (Shanghai) Limited, Shanghai, China

Amir T. Fathi, MD¹, Ghayas C. Issa, MD², Eunice S. Wang, MD³, Harry Erba, MD, PhD^4*, Jessica Altman, MD⁵, Suresh Kumar Balasubramanian, MD^6,7, Gail J. Roboz, MD⁸, Gary J. Schiller, MD⁹, Christine M. McMahon, MD¹⁰, Neil D. Palmisiano, MD, MS¹¹, Mark B Juckett, M.D., M.H.C.M.¹², Yazan F. Madanat, MD¹³, Marcello Rotta, MD^14*, Keith W. Pratz, MD¹⁵, George Yaghmour, MD¹⁶, Kalyan Nadiminti, MBBS¹⁷, Helen Wei, PhD^18*, Marcie Riches, MD^18*, Daniel Corum, PhD^18*, Mollie Leoni, MD^18*, Stephen Dale, MD^18* and Amer M. Zeidan, MBBS, MHS¹⁹

¹Massachusetts General Hospital, Harvard Medical School, Boston, MA
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁴Duke Cancer Institute, Durham, NC
⁵Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
⁶Department of Oncology, Karmanos Cancer Institute/ Wayne State University, Detroit, MI
⁷Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁸Weill Cornell Medicine and The New York Presbyterian Hospital in New York City, New York, NY
⁹David Geffen School of Medicine at UCLA, Los Angeles, CA
¹⁰Anschutz Medical Campus, Division of Hematology, University of Colorado School of Medicine, Aurora, CO
¹¹Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
¹²Department of Hematology, University of Minnesota, Minneapolis, MN
¹³The University of Texas Southwestern Medical Center, Dallas, TX
¹⁴Colorado Blood Cancer Institute, Denver, CO
¹⁵Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
¹⁶University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA
¹⁷Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI
¹⁸Kura Oncology, Inc., San Diego, CA
¹⁹Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT

Mojca Jongen-Lavrencic, MD, PhD¹, Thomas Pabst², Pierre Bories^3*, Laimonas Griškevičius, MD, PhD^4*, Gerwin Huls⁵, David C. de Leeuw, MD, PhD^6*, Steffen Boettcher, MD^7*, Arnaud Pigneux, MD, PhD^8*, Nicolas Boissel, MD, PhD⁹, Mariola Dymkowska, MD^10*, Christiane Andrieu, PhD^10*, Oliver Schönborn-Kellenberger, MSc^11*, Paul G. Baverel, PhD^10*, Zita Arany, MD, PhD^10*, Elena Fernandez, PhD^10*, Ana-Maria Florescu, PhD^10*, Michael P. Sanderson, PhD^10*, Anne Goubier, PhD^10*, Vladimir Kirkin, PhD^10*, Philippe Legenne, MD^10* and Marion Subklewe, MD¹²

¹Erasmus University Medical Center, Rotterdam, Netherlands
²Department of Medical Oncology, Inselspital, University Hospital, Bern, Switzerland
³UCT-Oncopole, Toulouse, France
⁴Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
⁵Department of Experimental Hematology, University Medical Center Groningen, Groningen, Netherlands
⁶Amsterdam University Medical Center, Amsterdam, Netherlands
⁷University of Zurich and University Hospital, Zurich, Switzerland
⁸Centre Hôspitalier Universitaire, Bordeaux, France
⁹Hôpital Saint-Louis, APHP, Université Paris Cité, Paris, France
¹⁰Molecular Partners AG, Zurich-Schlieren, Switzerland
¹¹Cogitars GmbH, Heidelberg, Germany
¹²Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany

Min Wu, MD, PhD^1*, Yunxiang Zhang, MD, PhD^1*, Wen Wu^2*, Zheng Ge, MD, PhD³, Ligen Liu, MD⁴, Chunyan Ji⁵, Weiying Gu, PhD^6*, Chunling Wang, PhD^7*, Yanli Zhang, MD^8*, Wei Yang, MD^9*, Fuling Zhou, PhD¹⁰, Zhengping Yu, MD^3*, Min Ji, MD, PhD^5*, Banghe Ding^7*, Shudong Wang, PhD, FRSC^11,12*, Lijun Wei, PhD^13*, Hengwen Song, MD^13*, Yan Zhou, MS^13*, Bomin Yin^13*, Zhichao Shao^13*, Mengdan Sun^13*, Qi Jiang, MD^13*, Junjie Lu^13* and Junmin Li, MD, PhD^1*

¹Shanghai Institute of Hematology, State Key Laboratory for Medical Genomics, National Research Center for Translational Medicine, Ruijin Hospital affiliated to School of Medicine, Shanghai Jiao Tong University, Shanghai, China
²Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
³Department of Hematology, Zhongda Hospital, School of Medicine, Southeast University, Institute of Hematology Southeast University, Nanjing, China
⁴Department of Hematology, Shanghai Tongren Hospital Affilated to Shanghai Jiaotong University, Shanghai, China
⁵Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
⁶Department of Hematology, Changzhou First People's Hospital, Third Affiliated to Soochow University, Changzhou, China
⁷Department of Hematology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huai'an, China
⁸Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
⁹Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China
¹⁰Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China
¹¹Drug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, Australia
¹²Aucentra Therapeutics Pty. Ltd, Adelaide, Australia
¹³Changzhou Qianhong Biopharma Co.,Ltd., Changzhou, China

Jennifer Marvin-Peek, MD¹, Himachandana Atluri, MD¹, Nicholas J. Short, MD¹, Abhishek Maiti, MBBS¹, Koichi Takahashi, MD, PhD², Sanam Loghavi, MD³, Curtis A Lachowiez, MD⁴, Yesid Alvarado Valero, MD¹, Guillermo Montalban-Bravo, MD¹, Koji Sasaki, MD¹, Fadi G. Haddad, MD¹, Ghayas C. Issa, MD¹, Lucia Masarova, MD¹, Hussein A. Abbas, MD, PhD¹, Michael Andreeff, MD, PhD⁵, Gautam Borthakur, MD⁵, Jillian Mullin, BA, RN, MN^1*, George Donovan Tippett, BS, BSN, RN^1*, Kelly S. Chien, MD⁶, Danielle Hammond, MD¹, Jo Ishizawa, MD, PhD⁵, Nitin Jain, MD¹, Patrick K. Reville, MD, MPH¹, Mahesh Swaminathan, MD⁷, Musa Yilmaz, MD^1*, Naval Daver, MD⁸, Tapan M. Kadia, MD¹, Farhad Ravandi, MBBS⁹, Guillermo Garcia-Manero, MD¹, Hagop M. Kantarjian, MD¹ and Courtney D. DiNardo, MD, MSc¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Knight Cancer Institute, Oregon Health & Science University, Houston, TX
⁵Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Leukemia, MD Anderson, Houston, TX
⁷Department of Leukemia, The University of Texas MD Anderson Cancer Center, Missouri City, TX
⁸MD Anderson Cancer Center, Houston, TX
⁹Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX